Skip to main content
Log in

Role of Endogenous Agonists of Opioid Receptors in the Regulation of Heart Resistance to Postischemic Reperfusion Injury

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Intravenous injection of nonselective antagonists of opioid receptors (OR) naltrexone (5 mg/kg) and naloxone methiodide (5 mg/kg), selective δ1-OR antagonist BNTX (0.7 mg/kg), selective δ2-OR blocker naltriben (0.3 mg/kg), selective κ-OR antagonist norbinaltorphimine (2 mg/kg), and selective blocker of ORL1 opioid receptors JTC-801 (0.1 mg/kg) produced no effect on reperfusion injury to the heart in rats narcotized with α-chloralose. In contrast, selective μ-OR antagonist CTAP (1 mg/kg) limited the infarct size, although this effect was not observed at a lower CTAP concentration of 0.1 mg/kg. Probably, the myocardial infarct size-limiting effect of CTAP was associated with activation of the non-opioid receptors. It was hypothesized that endogenous OR agonists did not affect heart resistance to reperfusion injury in unadapted rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lishmanov IB, Maslov LN, Naumova AV, Bogomaz SA. μ-Opiate receptor activation and increase in heart resistance to ischemic and reperfusion injury. Ross. Fiziol. Zh. 1998;84(11):1223-1230.

    CAS  Google Scholar 

  2. Guo HT, Zhang RH, Zhang Y, Zhang LJ, Li J, Shi QX, Wang YM, Fan R, Bi H, Yin W, Pei JM. Endogenous κ-opioid peptide mediates the cardioprotection induced by ischemic postconditioning. J. Cardiovasc. Pharmacol. 2011;58(2):207-215.

    Article  CAS  PubMed  Google Scholar 

  3. Jang Y, Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z. Postconditioning prevents reperfusion injury by activating deltaopioid receptors. Anesthesiology. 2008;108(2):243-250.

    Article  CAS  PubMed  Google Scholar 

  4. Ludvigsen E, Carlsson C, Tiensuu Janson E, Sandler S, Stridsberg M. Somatostatin receptor 1-5; expression profiles during rat development. Ups. J. Med. Sci. 2015;120(3):157-168.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Maslov LN, Khaliulin I, Oeltgen PR, Naryzhnaya NV, Pei JM, Brown SA, Lishmanov YB, Downey JM. Prospects for creation of cardioprotective and antiarrhythmic drugs based on opioid receptor agonists. Med Res Rev. 2016;36(5):871-923.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Maslov LN, Lishmanov YB, Oeltgen PR, Barzakh EI, Krylatov AV, Govindaswami M, Brown SA. Activation of peripheral delta2 opioid receptors increases cardiac tolerance to ischemia/reperfusion injury. Involvement of protein kinase C, NO-synthase, KATP channels and the autonomic nervous system. Life Sci. 2009;84(19-20):657-663.

    Article  CAS  PubMed  Google Scholar 

  7. Maslov LN, Naryzhnaia NV, Tsibulnikov SY, Kolar F, Zhang Y, Wang H, Gusakova AM, Lishmanov YB. Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia. Life Sci. 2013;93(9-11):373-379.

    Article  CAS  PubMed  Google Scholar 

  8. Murphy DB, Murphy MB. Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: a peripheral mechanism. J. Cardiovasc. Pharmacol. 1999;33(1):122-125.

    Article  CAS  PubMed  Google Scholar 

  9. Neckár J, Sźárszoi O, Herget J, Ostádal B, Kolár F. Cardioprotective effect of chronic hypoxia is blunted by concomitant hypercapnia. Physiol. Res. 2003;52(2):171-175.

    PubMed  Google Scholar 

  10. Romano MA, McNish R, Seymour EM, Traynor JR, Bolling SF. Differential effects of opioid peptides on myocardial ischemic tolerance. J. Surg. Res. 2004;119(1):46-50.

    Article  CAS  PubMed  Google Scholar 

  11. Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J. Mol. Cell. Cardiol. 1997;29(8):2187-2195.

    Article  CAS  PubMed  Google Scholar 

  12. Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, Patel HH. Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci. 2007;81(15):1223-1237.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Yamada H, Nakamoto H, Suzuki Y, Ito T, Aisaka K. Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801. Br. J. Pharmacol. 2002;135(2):323-332.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. S. Gorbunov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 7, pp. 25-28, July, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gorbunov, A.S., Vaizova, O.E., Belousov, M.V. et al. Role of Endogenous Agonists of Opioid Receptors in the Regulation of Heart Resistance to Postischemic Reperfusion Injury. Bull Exp Biol Med 164, 18–20 (2017). https://doi.org/10.1007/s10517-017-3916-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3916-6

Key Words

Navigation